Validation

A Proven & Validated Technology

Ronawk’s platform is not theoretical. Over 100 cell types have been validated using Bio-OS. Ronawk subsidizes its R&D with collaborators including major cancer centers and global cell suppliers. U.S. regulators are exploring Bio-OS as a new biomanufacturing standard. This foundation de-risks the platform and demonstrates real-world viability.

Nov 2025

Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High Quality Mesenchymal Stem Cells and Biologics

Nov 2025

The Amnion Foundation, Inc partners with Ronawk, Inc to Advance Perinatal Stem Cell Research.

Oct 2025

Comparison of 3D culture systems on mesenchymal stem cell longevity, regenerative potential, and secretome production.

Sep 2024

Nikon Application Note: Resolving subcellular detail in tissue mimetic culture.

Sep 2024

Translational Research in Advanced Tissue Engineering Aboard the International Space Station.

Aug 2023

A method for temporal spatial multivariate genomic analysis of acute wound healing via tissue stratification: a porcine negative pressure therapy pilot study.